What are the Common INSTIs Used in Pediatric Patients?
Several INSTIs are approved for use in pediatric patients, including: - Raltegravir: Approved for use in infants as young as 4 weeks old. - Dolutegravir: Approved for children aged 6 years and older, and in some cases for younger children. - Elvitegravir: Typically used in combination with other antiretrovirals.
